Register here.
First and only single-use, professional CGM system with blinded or unblinded mode
Dexcom, Inc. (NASDAQ:DXCM) announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM)...
Join Dexcom at the upcoming AADE conference from August 9-12, 2019, in Houston, TX. Attendees are invited to attend a special Dexcom product theater and participate in the Dexcom DANA Technology Workshop (details for both...
The ATDC conference will be held on July 11-14, 2019 in Keystone, CO. This event will focus on using new technologies to overcome challenges in day-to-day management of diabetes. Clinical studies and the benefits of Dexcom...
If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.
If you are a Dexcom User or Patient, please contact Dexcom here.
The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.
